Devonian Health Group Inc. (TSXV:GSD)
0.1800
0.00 (0.00%)
May 1, 2025, 9:30 AM EDT
Devonian Health Group Revenue
Devonian Health Group had revenue of 8.83M CAD in the quarter ending January 31, 2025, with 274.83% growth. This brings the company's revenue in the last twelve months to 29.04M, up 457.64% year-over-year. In the fiscal year ending July 31, 2024, Devonian Health Group had annual revenue of 17.82M with 659.60% growth.
Revenue (ttm)
29.04M
Revenue Growth
+457.64%
P/S Ratio
0.92
Revenue / Employee
4.15M
Employees
8
Market Cap
26.68M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 17.82M | 15.47M | 659.60% |
Jul 31, 2023 | 2.35M | 40.20K | 1.74% |
Jul 31, 2022 | 2.31M | 830.50K | 56.32% |
Jul 31, 2021 | 1.47M | -668.47K | -31.19% |
Jul 31, 2020 | 2.14M | -1.86M | -46.49% |
Jul 31, 2019 | Pro | Pro | Pro |
Jul 31, 2018 | Pro | Pro | Pro |
Jul 31, 2017 | Pro | Pro | Pro |
Jul 31, 2016 | Pro | Pro | Pro |
Jul 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.64B |
dentalcorp Holdings | 1.55B |
Sienna Senior Living | 893.16M |
Trulieve Cannabis | 1.71B |
Extendicare | 1.47B |
Curaleaf Holdings | 1.93B |
WELL Health Technologies | 919.69M |
Cronos Group | 169.23M |
Devonian Health Group News
- 4 days ago - Devonian Health Group Announces Reinstatement of Quotation on the TSXV - Financial Post
- 2 months ago - Devonian Announces Positive in Vivo Results of Thykamine™ on Gene Expression Associated With Fibrosis - Financial Post
- 2 months ago - Devonian Announces the Filing of a New Provisional Patent Application Relating to the Use of Thykamine™ for Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Financial Post
- 3 months ago - Devonian Health Group Inc. Reports Superior Anti-Inflammatory Potency of Thykamine™ in Comparative In Vitro Study - Financial Post